- Fund Type: ETF
- Objective: Sector Fund-Health & Biotech
- Asset Class: Equity
- Geographic Focus: U.S.
Health Care Select Sector SPDR Fund
+ Add to WatchlistXLV:US
49.1200 USD 0.1500 0.30%As of 20:04:02 ET on 05/24/2013.
Snapshot for Health Care Select Sector SPDR Fund (XLV)
| Open: | 49.0800 | High - Low: | 49.2000 - 48.7400 | Primary Exchange: | NYSE Arca |
|---|---|---|---|---|---|
| Volume: | 5,906,747 | 52-Week Range: | 35.3800 - 50.4000 | Beta vs IXV: | 0.9932 |
Fund Profile & Information for XLV
Health Care Select Sector SPDR Fund is an exchange-traded fund incorporated in the USA. The Fund's objective is to provide investment results that correspond to the performance of The Health Care Select Sector Index. The Index includes companies involved in health care equipment and supplies, health care providers and services, biotechnology & pharmaceuticals.
| Inception Date: | 1998-12-16 | Telephone: | 1-866-787-2257 |
|---|---|---|---|
| Managers: | JOHN A TUCKER | ||
| Web Site: | www.spdrs.com | ||
Fundamentals for XLV
| NAV | (on 2013-05-24) 49.1398 |
|---|---|
| Assets (M) | (on 2013-05-24) 7,337.3250 |
| Shares out (M) | 149.32 |
| Market Cap (M) | 7,334.37 |
| % Premium | -0.04 |
| Average 52-Week % Premium | -0.0024 |
| Fund Leveraged | N |
Dividends for XLV
| Dividend Type | Income |
|---|---|
| Dividend Frequency | Quarter |
| Last Dividend Net | (on 2013-03-15) 0.1942 |
| Dividend Yield (ttm) | 1.65% |
Performance for XLV
| 1-Month | +3.72% | 1-Year | +37.26% |
|---|---|---|---|
| 3-Month | +13.70% | 3-Year | +22.00% |
| Year To Date | +23.70% | 5-Year | +11.61% |
| Expense Ratio | 0.18 |
Top Fund Holdings for XLV
Filing Date: 05/23/2013| Name | Position | Value | % of Total |
|---|---|---|---|
| Johnson & Johnson | 10,893,575 | 950,028,676 | 12.904% |
| Pfizer Inc | 28,015,830 | 815,540,811 | 11.077% |
| Merck & Co Inc | 11,778,215 | 557,462,916 | 7.572% |
| Gilead Sciences Inc | 5,932,784 | 329,150,856 | 4.471% |
| Amgen Inc | 2,916,668 | 308,058,474 | 4.184% |
| Bristol-Myers Squibb Co | 6,413,254 | 301,422,938 | 4.094% |
| AbbVie Inc | 6,159,862 | 286,987,971 | 3.898% |
| UnitedHealth Group Inc | 4,026,788 | 251,110,500 | 3.411% |
| Biogen Idec Inc | 941,580 | 219,030,340 | 2.975% |
| Eli Lilly & Co | 3,890,346 | 212,957,540 | 2.893% |
Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
- 1
- 2
- 3
- 4
- 5
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page